Global Therapeutic Vaccines Market (Product, Technology, Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013-2020

Therapeutic vaccines are provided to the body during treatment of specific diseases. This vaccine triggers and strengthens the immune response of the body to act against a disease. In 2011, the global therapeutic vaccines market was valued at $294 million. This vaccine has expanded the horizon of chronic disease treatment. However, there is a need to get a vaccine for specific disease to be approved by the FDA. Increasing cases of chronic diseases and need for effective treatment is acting as key driver for this market. Various pharmaceutical companies are working to develop novel vaccines for diseases such as lung cancer, breast cancer, Alzheimer, etc. However, these vaccine developments are in pipeline and yet to be commercialized.

Inefficient Research & development and reimbursement policies are primary factors restraining the market. Furthermore, as the market is in nascent stage, strict regulatory implications are also expected to deter growth. However, as the vaccine carries potential to treat many chronic diseases, these restraints would get weaker with time. This report delivers micro level analysis of the therapeutic vaccine market and its opportunities in various disease treatments.

Key market players profiled in this report include Affiris, Antigenics, Argos Therapeutics, Bavarian Nordic, Biovest International, Celldex Therapeutics, Cel-Sci, Celtic Pharma, Curevac And Cytos Biotechnology.

KEY BENEFITS 

• The report provides strategic analysis of the current market trend and delivers expected trends that would assist stakeholders to take strategic and actionable decisions
• Present market quantitative scenario and estimations through 2013-2020
• Analysis of the market factors in various geographic regions and help understand business opportunities
• Identification of key investment pockets for various applications, services and geographies
• Identification of key players and their business performance analysis based on strategies followed by them
• Identification of key application segments based on future potential and growth prospects 
• Top factors affecting the market and analysis of probable changes in impact of those factors
• Analysis and evaluation of market trends to provide deep-dive intelligence into every market segment
• Competitive analysis based on strategies followed by key players to effectively plan and execute business plan
• Micro level analysis based on application, service and geography

KEY MARKET SEGMENTS 

BY PRODUCTS 

• Addiction Vaccines
  • Cocaine Addiction Vaccines
  • Nicotine Addiction Vaccines
• Autoimmune Disease Vaccines
  • Diabetes (Type 1)
    • Diamyd (RHGAD65)
    • BHT-3021
    • Tovaxin
    • TNFaKinoid
  • Cancer Vaccines
    • Cancer vaccines in development 
    • Cancer vaccines approved for use 
• Infectious Disease Vaccines
  • HIV/AIDS
  • Other infectious disease vaccines (outside HIV)
  • Hepatitis C
• Neurological disease vaccines 
  • Parkinson’s disease vaccine
  • Other disease vaccines

BY TECHNOLOGIES

• Autologous vaccines 
• Allogeneic vaccines 

BY GEOGRAPHY 

• North America
• Asia Pacific